The Research and Development team at HiFiBiO Therapeutics focuses on leveraging advanced single-cell profiling technologies to drive the discovery and development of innovative antibody drugs aimed at treating cancer and autoimmune disorders. Comprising a diverse group of experts, including scientists and clinical operations professionals, the team collaborates closely with external partners to enhance therapeutic strategies and accelerate the transition from laboratory research to clinical applications.
Aurélien Marabelle
Scientific Advisor
Francisco Adrian
Chief Scientific Officer
Jinping Gan
VP, Global Head of Research
Leslie Kean
Scientific Advisor
Michael Croft
Scientific Advisor
Peter Ho
Scientific Advisor
Roshan Kumar
Senior Director, External Inno...
Sebastian Amigorena
Scientific Advisor
Wendye Robbins
Scientific Advisor
Yun-Yueh Lu
Senior Director, Discovery Bio...
View all